Myocarditis Revealing a Pathogenic Desmoplakin (DSP) Variant: Implications for Genetic Testing Pathways.
- 1School of Medicine, Anglia Ruskin University, Chelmsford, GBR.
- 2Essex Cardiothoracic Centre, Basildon and Thurrock University Hospitals NHS Foundation Trust, Basildon, GBR.
Abstract
Desmoplakin (DSP) variants are associated with arrhythmogenic cardiomyopathy and can present with myocarditis-like "hot phases" before overt structural disease develops. We report a 30-year-old woman who presented with chest tightness, palpitations, and elevated troponin and was diagnosed with acute myocarditis on cardiac magnetic resonance imaging. In view of a family history of myocarditis in her younger sister, genomic testing was pursued following multidisciplinary review, despite the absence of a dedicated myocarditis testing pathway. A pathogenic heterozygous DSP splice-site variant (c.939+1G>A) was identified and was also detected in her asymptomatic father, who had a normal cardiac phenotype. Over the following 16 months, the patient experienced eight further episodes of myocarditis-like symptoms, resulting in nine episodes in total. These were characterized by recurrent chest pain and mild troponin elevation with minimal or no elevation of inflammatory markers, while biventricular systolic function remained preserved. This case illustrates recurrent myocarditis as a potential early manifestation of DSP-related cardiomyopathy, including in the absence of global systolic dysfunction. It also highlights the diagnostic value of genomic testing in patients with recurrent myocarditis, particularly in the presence of a relevant family history. Identification of a pathogenic DSP variant can inform longitudinal surveillance, prognostic assessment, and cascade screening of relatives and supports consideration of clearer genomic testing pathways for selected patients presenting with recurrent myocarditis.
Related
- Integrated multi-omics identifies distinct immune signatures with diagnostic and therapeutic implications in immune checkpoint inhibitor-induced myocarditis
- Age-stratified reporting of immune checkpoint inhibitor-associated myocarditis: disproportionality is amplified in older adults, with implications for geriatric oncology
- PIM1 in myeloproliferative neoplasms: potential pathogenic and therapeutic implications
- Dry eye disease in thyroid eye disease: A narrative review of pathogenic mechanisms and therapeutic implications
- Unraveling the molecular basis of ADC-related interstitial lung disease: from structural determinants to pathogenic pathways and mitigation strategies
BibTeX
@article{reka2026myocarditis,
title = {{Myocarditis Revealing a Pathogenic Desmoplakin (DSP) Variant: Implications for Genetic Testing Pathways.}},
author = {Blend Reka and Jason N Dungu},
journal = {Cureus},
year = {2026},
month = sep,
doi = {10.7759/cureus.116569},
url = {https://europepmc.org/article/MED/42903300},
note = {CC BY},
}
RIS
TY - JOUR
TI - Myocarditis Revealing a Pathogenic Desmoplakin (DSP) Variant: Implications for Genetic Testing Pathways.
AU - Blend Reka
AU - Jason N Dungu
PY - 2026
DA - 2026/09/20
JO - Cureus
DO - 10.7759/cureus.116569
UR - https://europepmc.org/article/MED/42903300
AB - Desmoplakin (DSP) variants are associated with arrhythmogenic cardiomyopathy and can present with myocarditis-like "hot phases" before overt structural disease develops. We report a 30-year-old woman who presented with chest tightness, palpitations, and elevated troponin and was diagnosed with acute myocarditis on cardiac magnetic resonance imaging. In view of a family history of myocarditis in her younger sister, genomic testing was pursued following multidisciplinary review, despite the absence of a dedicated myocarditis testing pathway. A pathogenic heterozygous DSP splice-site variant (c.939+1G>A) was identified and was also detected in her asymptomatic father, who had a normal cardiac phenotype. Over the following 16 months, the patient experienced eight further episodes of myocarditis-like symptoms, resulting in nine episodes in total. These were characterized by recurrent chest pain and mild troponin elevation with minimal or no elevation of inflammatory markers, while biventricular systolic function remained preserved. This case illustrates recurrent myocarditis as a potential early manifestation of DSP-related cardiomyopathy, including in the absence of global systolic dysfunction. It also highlights the diagnostic value of genomic testing in patients with recurrent myocarditis, particularly in the presence of a relevant family history. Identification of a pathogenic DSP variant can inform longitudinal surveillance, prognostic assessment, and cascade screening of relatives and supports consideration of clearer genomic testing pathways for selected patients presenting with recurrent myocarditis.
SN - 2168-8184
ER -